Prio Wealth Limited Partnership’s Anika Therapeutics ANIK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
$711K Hold
28,800
0.02% 172
2024
Q2
$730K Hold
28,800
0.02% 166
2024
Q1
$732K Hold
28,800
0.02% 169
2023
Q4
$653K Hold
28,800
0.02% 173
2023
Q3
$537K Hold
28,800
0.02% 180
2023
Q2
$748K Hold
28,800
0.03% 160
2023
Q1
$827K Hold
28,800
0.03% 144
2022
Q4
$852K Sell
28,800
-750
-3% -$22.2K 0.03% 147
2022
Q3
$703K Hold
29,550
0.03% 153
2022
Q2
$660K Hold
29,550
0.03% 163
2022
Q1
$742K Hold
29,550
0.02% 160
2021
Q4
$1.06M Hold
29,550
0.03% 148
2021
Q3
$1.26M Sell
29,550
-750
-2% -$31.9K 0.04% 141
2021
Q2
$1.31M Buy
30,300
+1,500
+5% +$65K 0.04% 141
2021
Q1
$1.18M Sell
28,800
-1,260
-4% -$51.4K 0.04% 142
2020
Q4
$1.36M Sell
30,060
-740
-2% -$33.5K 0.05% 133
2020
Q3
$1.09M Hold
30,800
0.05% 135
2020
Q2
$1.16M Hold
30,800
0.05% 127
2020
Q1
$890K Hold
30,800
0.05% 129
2019
Q4
$1.6M Hold
30,800
0.07% 120
2019
Q3
$1.69M Hold
30,800
0.08% 118
2019
Q2
$1.25M Hold
30,800
0.06% 133
2019
Q1
$931K Sell
30,800
-1,000
-3% -$30.2K 0.04% 142
2018
Q4
$1.07M Sell
31,800
-500
-2% -$16.8K 0.06% 135
2018
Q3
$1.36M Hold
32,300
0.06% 137
2018
Q2
$1.03M Hold
32,300
0.05% 143
2018
Q1
$1.61M Hold
32,300
0.08% 124
2017
Q4
$1.74M Hold
32,300
0.08% 121
2017
Q3
$1.87M Hold
32,300
0.09% 117
2017
Q2
$1.59M Buy
32,300
+500
+2% +$24.7K 0.08% 124
2017
Q1
$1.38M Hold
31,800
0.07% 128
2016
Q4
$1.56M Hold
31,800
0.08% 126
2016
Q3
$1.52M Hold
31,800
0.08% 127
2016
Q2
$1.71M Sell
31,800
-2,000
-6% -$107K 0.09% 119
2016
Q1
$1.51M Hold
33,800
0.08% 127
2015
Q4
$1.29M Hold
33,800
0.07% 131
2015
Q3
$1.08M Buy
33,800
+2,800
+9% +$89.1K 0.06% 141
2015
Q2
$1.02M Hold
31,000
0.05% 148
2015
Q1
$1.28M Buy
31,000
+1,000
+3% +$41.2K 0.06% 136
2014
Q4
$1.22M Hold
30,000
0.06% 136
2014
Q3
$1.1M Hold
30,000
0.06% 138
2014
Q2
$1.39M Sell
30,000
-5,000
-14% -$232K 0.07% 132
2014
Q1
$1.44M Hold
35,000
0.07% 132
2013
Q4
$1.34M Hold
35,000
0.07% 136
2013
Q3
$836K Hold
35,000
0.05% 154
2013
Q2
$595K Buy
+35,000
New +$595K 0.04% 170